Correction to Synthesis and Antineoplastic Evaluation of Novel

Jan 27, 2017 - Design, Synthesis, and Biological Evaluation of Novel, Non-Brain-Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Ox...
0 downloads 7 Views 107KB Size
Addition/Correction pubs.acs.org/jmc

Correction to Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles Valentina Nieddu, Giansalvo Pinna, Irene Marchesi, Luca Sanna, Battistina Asproni, Gerard A. Pinna, Luigi Bagella,* and Gabriele Murineddu* Journal of Medicinal Chemistry 2016, 59, 10451−10469. DOI: 10.1021/acs.jmedchem.6b00468 Page 10453. In lines 6−8 of the right-hand column, the sentence “To evaluate the effect of the bioisosteric replacement of the pyrazole nucleous of 1a, first we synthesized compound 2a and analogues 2b−i.” should be deleted. Page 10453. In lines 14−15 of the right-hand column, the compound should be “1,4-dihydroindenopyrrole” instead of “1,4-dihydroindenopyrazole”. Page 10453. In line 40 of the right-hand column, the text “1,4-dihydroindenopyrazole moiety as 1a, but they displayed” should be “1,4-dihydroindenopyrazole moiety and displayed”.

© XXXX American Chemical Society

A

DOI: 10.1021/acs.jmedchem.7b00052 J. Med. Chem. XXXX, XXX, XXX−XXX